tiprankstipranks
Advertisement
Advertisement

SNYNF Stock Latest News

AI Daily: Amazon’s AWS commits $1B toward new unit
The FlyAI Daily: Amazon’s AWS commits $1B toward new unit
4d ago
AZN
BMY
Anthropic takes aim at pharma industry with Claude Science, STAT reports
PremiumThe Fly
Anthropic takes aim at pharma industry with Claude Science, STAT reports
4d ago
AZN
BMY
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances Novel Multiple Sclerosis Therapy Toward Phase 2 Trials
PremiumTipRanks Newswire
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances Novel Multiple Sclerosis Therapy Toward Phase 2 Trials
11d ago
SNY
BIIB
MacroGenics to receive $24.5M milestone payment from Sanofi
PremiumThe Fly
MacroGenics to receive $24.5M milestone payment from Sanofi
12d ago
SNY
MGNX
Sanofi appoints Paulo Fontoura as Global Head of R&D
PremiumThe Fly
Sanofi appoints Paulo Fontoura as Global Head of R&D
12d ago
SNY
Sanofi investors likely to view new R&D head as a positive, says BofA
PremiumThe FlySanofi investors likely to view new R&D head as a positive, says BofA
12d ago
SNY
CHRO
Sanofi price target lowered to EUR 95 from EUR 100 at Deutsche Bank
Premium
The Fly
Sanofi price target lowered to EUR 95 from EUR 100 at Deutsche Bank
19d ago
SNY
CMS proposes to lock in lower prices in Medicare drug price negotiation program
Premium
The Fly
CMS proposes to lock in lower prices in Medicare drug price negotiation program
19d ago
AZN
BMY
Dianthus’ new CAPTIVATE responder rate beat expectations, says Raymond James
PremiumThe Fly
Dianthus’ new CAPTIVATE responder rate beat expectations, says Raymond James
22d ago
SNY
DNTH
Sanofi’s ARAVA Safety Study in Saudi Arabia: What Investors Should Know Now
PremiumCompany Announcements
Sanofi’s ARAVA Safety Study in Saudi Arabia: What Investors Should Know Now
23d ago
SNYNF
Dianthus price target raised to $132 from $110 at Jefferies
PremiumThe Fly
Dianthus price target raised to $132 from $110 at Jefferies
24d ago
SNY
DNTH
Sanofi Ends Phase 2 Amlitelimab Alopecia Trial, Nudging Investor Expectations
PremiumCompany Announcements
Sanofi Ends Phase 2 Amlitelimab Alopecia Trial, Nudging Investor Expectations
24d ago
SNYNF
Midday Fly By: SpaceX IPO oversubscribed, Chewy reports in-line Q1
PremiumThe FlyMidday Fly By: SpaceX IPO oversubscribed, Chewy reports in-line Q1
24d ago
F
SN
Buy Dianthus on weakness amid ‘overdone’ selloff, says H.C. Wainwright
Premium
The Fly
Buy Dianthus on weakness amid ‘overdone’ selloff, says H.C. Wainwright
24d ago
SNY
DNTH
Video: Cracker Barrel advances after beat and raise report
Premium
The Fly
Video: Cracker Barrel advances after beat and raise report
24d ago
SNY
CBRL
Stifel says Sanofi stopping MOBILIZE study potentially positive for Dianthus
PremiumThe Fly
Stifel says Sanofi stopping MOBILIZE study potentially positive for Dianthus
24d ago
SNY
DNTH
Dianthus sinks after Sanofi halts CIDP Phase 3 study
PremiumThe Fly
Dianthus sinks after Sanofi halts CIDP Phase 3 study
24d ago
SNY
DNTH
Sanofi to halt riliprubart Mobilize phase 3 study
PremiumThe Fly
Sanofi to halt riliprubart Mobilize phase 3 study
24d ago
SNY
Acting FDA head vows to block political interference, Endpoint News says
PremiumThe Fly
Acting FDA head vows to block political interference, Endpoint News says
30d ago
AZN
BMY
RAPID Real‑World Dupixent Data Could Extend Regeneron and Sanofi’s Asthma Edge
PremiumCompany AnnouncementsRAPID Real‑World Dupixent Data Could Extend Regeneron and Sanofi’s Asthma Edge
30d ago
REGN
Snowflake says Sanofi selects Snowflake Cortex AI for drug development
Premium
The Fly
Snowflake says Sanofi selects Snowflake Cortex AI for drug development
1M ago
SNY
SNOW
FDA issues draft guidance to help accelerated cell, gene therapies for patients
Premium
The Fly
FDA issues draft guidance to help accelerated cell, gene therapies for patients
1M ago
AZN
BMY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >